Mirthala Flores-García, PhD, is a Biomedical Researcher in the Department of Molecular Biology at the Instituto Nacional de Cardiología Ignacio Chávez. Her research integrates cardiovascular pharmacology, molecular biology, and translational medicine to investigate the mechanisms regulating platelet function, thrombosis, and cardiometabolic risk. Her work has focused on the pharmacological modulation of platelet aggregation and the identification of bioactive molecules with potential antiplatelet and antithrombotic properties. Early studies examined the influence of environmental exposures on cardiovascular pathology and thrombotic risk. Subsequent research addressed the discovery and characterization of novel compounds capable of modulating platelet activation and thrombin generation, including copper-based complexes and naturally derived bioactive molecules that inhibit platelet aggregation without significantly altering coagulation pathways. More recently, her research has expanded toward molecular and translational approaches to cardiovascular disease, including the study of circulating biomarkers such as microRNAs and extracellular vesicles (microvesicles and exosomes) involved in vascular dysfunction and cardiometabolic disorders. Her work has also contributed to the identification of genetic and transcriptomic factors associated with peripheral artery disease, providing insights into molecular pathways underlying vascular pathology and thrombotic complications